Announcements Trials
Browse Landscape

Phase

Phase 4 3

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 7Lymphoid 4

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 86Leukemia 34Burkitt Lymphoma 19Lymphoma 17Leukemia, Biphenotypic, Acute 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, Myeloid, Acute 5Dendritic Cell Sarcoma, Interdigitating 5Neoplasm, Residual 4Lymphoma, Non-Hodgkin 3Philadelphia Chromosome 2Neoplasms 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Blast Crisis 2Thrombocytopenia 1Recurrence 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Lymphoproliferative Disorders 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Erythroblastic, Acute 1

Interventions

blinatumomab 16Cyclophosphamide 15fludarabine phosphate 8fludarabine 8Methotrexate 7Cytarabine 7Rituximab 6Vincristine 5Mercaptopurine 5Melphalan 4Daunorubicin 4obinutuzumab 3Whole-Body Irradiation 3Immunotherapy, Adoptive 3Granulocyte Colony-Stimulating Factor 3Etoposide 3Doxorubicin 3Dexamethasone 3Asparaginase 3tisagenlecleucel 2thymoglobulin 2pegaspargase 2Vindesine 2Thioguanine 2Teniposide 2Stem Cell Transplantation 2Radiotherapy 2Prednisone 2Prednisolone 2N,N-dicyclohexyl-isoborneol-10-sulfonamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Neoplasm, Residual × Daunorubicin × Lymphoid × Clear all
NCT05959720 2025-05-07

BRALLA

Instituto do Cancer do Estado de São Paulo

Recruiting
180 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00198991 2022-08-18

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

Goethe University

Phase 4 Completed
1,883 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00526175 2016-01-20

LAL-BR/2001: Study Treatment to Low Risk ALL

PETHEMA Foundation

Phase 4 Completed
150 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00199004 2010-08-23

Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab

Johann Wolfgang Goethe University Hospital

Phase 4 Completed
60 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡